Rolf Rau

Ratingen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Title Not Found

Title Not Found

Journal: Zeitschrift fur Rheumatologie

Published: December 01, 2023

Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).

Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).

Journal: Rheumatology and therapy

Published: November 29, 2023

Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).

Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).

Journal: Rheumatology and therapy

Published: September 20, 2023

Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).

Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA).

Journal: Rheumatology and therapy

Published: March 07, 2022

The 32nd emeriti meeting in Düsseldorf 9-12 September 2021

The 32nd emeriti meeting in Düsseldorf 9-12 September 2021

Journal: Zeitschrift fur Rheumatologie

Published: December 15, 2021

The Efficacy of Short-Term Bridging Strategies With High- and Low-Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Trial.

The Efficacy of Short-Term Bridging Strategies With High- and Low-Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Trial.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: July 13, 2021

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.

Journal: RMD open

Published: March 09, 2021

A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.

A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.

Journal: Patient preference and adherence

Published: March 29, 2018

Gold as an alternative in the treatment of RA patients with malignancies

Gold as an alternative in the treatment of RA patients with malignancies

Journal: Zeitschrift fur Rheumatologie

Published: August 26, 2016

Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.

Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.

Journal: Clinical and experimental rheumatology

Published: June 25, 2016

Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.

Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.

Journal: Clinical rheumatology

Published: August 03, 2015

Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis.

Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis.

Journal: Clinical and experimental rheumatology

Published: July 09, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026